Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
3.570
+0.050 (1.42%)
At close: Sep 30, 2026, 4:00 PM EDT
3.573
+0.003 (0.08%)
After-hours: Sep 30, 2026, 7:30 PM EDT
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $212.01 million as of September 30, 2026. Its market cap has decreased by -25.14% in one year.
Market Cap
212.01M
Enterprise Value
87.53M
1-Year Change
-25.14%
Ranking
Category
Stock Price
$3.57
ChartMarket Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $212.01M, a decrease of -62.51%. That is a compound annual growth rate of -15.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 212.01M | -30.58% |
| Dec 31, 2025 | 305.38M | 16.38% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cartesian Therapeutics | 220.86M |
| Compugen | 220.23M |
| Protalix BioTherapeutics | 218.75M |
| Anavex Life Sciences | 215.06M |
| Adagene | 211.50M |
| Whitehawk Therapeutics | 210.65M |
| Alector | 210.47M |
| NervGen Pharma | 205.37M |